Akums Drugs & Pharmaceuticals Ltd Share Price
(AKUMS)
₹531.15▲1.28%
as on 11:35AM, 30 Apr 2025
Akums Drugs & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹514.75Day's Price Range₹531.952 Week's Low
52 Week's High
₹40552-Week Price Range₹1,175.9
| Returns % | |
| 1 Month Return | + 10.92 % |
| 3 Month Return | -6 % |
| 1 Year Return | -34.14 % |
| Market Stats | |
| Previous Close | ₹524.45 |
| Open | ₹531.60 |
| Volume | 76.00K |
| Upper Circuit | ₹576.85 |
| Lower Circuit | ₹472.00 |
| Market Cap | ₹8,254.53Cr |
Akums Drugs & Pharmaceuticals Ltd Fundamentals
P/E Ratio
0PEG Ratio
0Market Cap
₹147.07 Cr
P/B Ratio
3.5
EPS
0Dividend Yield
0Sector
Pharmaceuticals
ROE
1.73
Mutual Fund Holdings of Akums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals Ltd Analyst Rating
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Akums Drugs & Pharmaceuticals Ltd. An average target of ₹750
Source: S&P Global Market Intelligence
Akums Drugs & Pharmaceuticals Ltd Share analysis
Akums Drugs & Pharmaceuticals Ltd price forecast by 3 analysts
Upside of43.01%
High
₹840
Target
₹750.00
Low
₹700
Akums Drugs & Pharmaceuticals Ltd target price ₹750, a slight upside of 43.01% compared to current price of ₹531.15. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Akums Drugs & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Akums Drugs & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Akums Drugs & Pharmaceuticals Ltd
Akums Drugs Partners with TNAU for R&D - 24 Apr, 2025
Akums Drugs and Pharmaceuticals has signed a Memorandum of Agreement with Tamil Nadu Agricultural University to enhance R&D in agri-based pharmaceutical formulations, focusing on sustainable resources and innovative solutions.
Insights on Akums Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 8.65% to 8.85% in Mar 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 5.54% to 6.11% in Mar 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 75.26% of holdings in Mar 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 6 months, AKUMS stock has moved down by -41.9%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 6.36% to 5.77% in Mar 2025 quarter
Akums Drugs & Pharmaceuticals Ltd Financials
Akums Drugs & Pharmaceuticals Ltd Index Inclusions
Akums Drugs & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 75.26% | 0.00 | |
| Foreign Institutions | 5.77% | 0.00 | |
| Mutual Funds | 6.11% | 0.00 | |
| Retail Investors | 8.85% | 0.00 | |
| Others | 4.01% | 0.00 |
Akums Drugs & Pharmaceuticals Ltd Key Indicators
Akums Drugs & Pharmaceuticals Ltd Valuation
Akums Drugs & Pharmaceuticals Ltd in the last 5 years
Lowest (29.26x)
November 18, 2024
Today (52.71x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (66.86x)
August 19, 2024
Akums Drugs & Pharmaceuticals Ltd Earnings and Dividends
Akums Drugs & Pharmaceuticals Ltd Earnings Results
Akums Drugs & Pharmaceuticals Ltd’s net profit fell -66.35% since last year same period to ₹65.18Cr in the Q3 2024-2025. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -0.05% fall in its net profits since last 3-months.
Read More about Earnings Results
Akums Drugs & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Akums Drugs & Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Akums Drugs & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA | |
| NA | ₹455.78 Cr | 40.14% | 0.51 | NA | NA |
About Akums Drugs & Pharmaceuticals Ltd
Revenue: ₹1,010.41Cr as on December 2024 (Q4 24)
Net Profit: ₹66.31Cr as on December 2024 (Q4 24)
Listing date: 06 Aug, 2024
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Akums Drugs & Pharmaceuticals Ltd
What is Akums Drugs & Pharmaceuticals Ltd price today?
Akums Drugs & Pharmaceuticals Ltd share price today stands at ₹531.15, Open: ₹531.6, Previous Close: ₹524.45, High: ₹531.9, Low: ₹514.75, 52 Week High: ₹1175.9, 52 Week Low: ₹405.
How to Buy Akums Drugs & Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Akums Drugs & Pharmaceuticals Ltd shares
What are today's traded volumes of Akums Drugs & Pharmaceuticals Ltd?
Today's traded volume of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is 76.00K.
What is today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd?
Today's market capitalisation of Akums Drugs & Pharmaceuticals Ltd(AKUMS) is ₹8254.53Cr.
What is the 52 Week High and Low Range of Akums Drugs & Pharmaceuticals Ltd?
How much percentage Akums Drugs & Pharmaceuticals Ltd is down from its 52 Week High?
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price is ₹531.15. It is down -54.83% from its 52 Week High price of ₹1175.9
How much percentage Akums Drugs & Pharmaceuticals Ltd is up from its 52 Week low?
Akums Drugs & Pharmaceuticals Ltd (AKUMS) share price is ₹531.15. It is up 31.15% from its 52 Week Low price of ₹405